Altered expression of microRNAs and B lymphocytes during Natalizumab therapy in multiple sclerosis-Reference-Cited by-同舟云学术

Altered expression of microRNAs and B lymphocytes during Natalizumab therapy in multiple sclerosis

Published:2021-06 Issue:6 Volume:7 Page:e07263
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Franzoi André Eduardo de Almeida,de Moraes Machado Fernanda Subtil,de Medeiros Junior Washigton Luiz Gomes,Bandeira Isabelle Pastor^ORCID,Brandão Wesley Nogueira,Gonçalves Marcus Vinicius Magno

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference69 articles.

1. An overview of high-efficacy drugs for multiple sclerosis: Gulf region expert opinion;Alroughani;Neurol. Ther.,2019

2. Increased expression of MicroRNA 551a by c-fos reduces focal adhesion kinase levels and blocks tumorigenesis;Anuj;Mol. Cell Biol.,2019

3. Impact of B cells to the pathophysiology of multiple sclerosis;Arneth;J. Neuroinflam.,2019

4. MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a;Aung;J. Neuroimmunol.,2015

5. Selection of first-line therapy in multiple sclerosis using risk-benefit decision analysis;Bargiela;Neurology,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNAs Associated with Disability Progression and Clinical Activity in Multiple Sclerosis Patients Treated with Glatiramer Acetate;Biomedicines;2023-10-12

2. The fluctuations of expression profiles of critical genes in the miRNA maturation process and pro-and anti-inflammatory cytokines in the pathogenesis and progression of multiple sclerosis;Molecular Biology Reports;2023-10-12

3. Unraveling the Immunopathogenesis of Multiple Sclerosis: The Dynamic Dance of Plasmablasts and Pathogenic T Cells;Biologics;2023-09-14

4. microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer Acetate;Frontiers in Immunology;2022-06-14